Indegene Limited — Investor Meet, 27-05-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Indegene reported FY26 revenue of INR 3510.5 Cr, marking a 29.4% CAGR (FY21-26), with a 19.4% adjusted EBITDA margin and over 100% Net Revenue Retention. The company views itself as an "AI-embedded, domain-deep operating partner" for life sciences, benefiting from GenAI as a structural tailwind. Management expresses excitement and determination for FY27, citing a 17% higher pipeline. Indegene aims to capture the consolidating ~$50B agency budget as AI drives Sales & Marketing centralization, evolving into integrated platform partners, targeting $500M+ near-term revenue.